Literature DB >> 18246602

IL-19 is involved in the pathogenesis of endotoxic shock.

Chung-Hsi Hsing1, Chiau-Juon Chiu, Lih-Yun Chang, Chuan-Chih Hsu, Ming-Shi Chang.   

Abstract

IL-19, a proinflammatory cytokine, belongs to the IL-10 family. IL-19 is induced in systemic inflammatory response syndrome, but its pathophysiological function in sepsis is unclear. Our aim was to determine the roles of IL-19 in endotoxin-induced tissue damage in vivo and in vitro. We examined serum levels of IL-19 in sepsis patients and healthy volunteers, determined the in vitro effects of IL-19 on lung epithelial cells, liver cells, and neutrophils, and analyzed the tissue expression of IL-19 and its receptors in murine endotoxic shock. Electroporation-mediated gene transfer of mouse IL-19-soluble receptor plasmid DNA was used to determine the effects of IL-19 depletion in preventing endotoxic shock-induced tissue damage in mice. We found that serum levels of IL-19 were higher in patients than in healthy volunteers (n = 28, P = 0.001). IL-19 induced apoptosis in lung epithelial cells and reactive oxygen species production in liver cells in vitro. IL-19 also promoted neutrophil chemotaxis, reduced neutrophil apoptosis, and induced the production of proinflammatory cytokines and chemokines (IL-1[beta], IL-6, IL-8, CCL5, and CXCL9) in lung epithelial cells. In LPS-challenged mice, transcripts of IL-19 and its receptors were up-regulated in heart, lung, liver, and kidney tissue. Neutrophil infiltration in lung and liver tissue, and serum levels of alanine transaminase and aspartate transaminase, were lower in mice electroporated with IL-19-soluble receptor plasmid DNA before LPS treatment compared with control mice. These results suggest that up-regulated IL-19 may be involved in lung and liver tissue injury in murine endotoxic shock.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18246602     DOI: 10.1097/shk.0b013e318067de40

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  17 in total

1.  Staphylococcus aureus Colonization Induces Strain-Specific Suppression of Interleukin-17.

Authors:  Aylana Reiss-Mandel; Carmit Rubin; Morad Zayoud; Galia Rahav; Gili Regev-Yochay
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

2.  Interleukin-19 in fetal systemic inflammation.

Authors:  Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Roberto Romero; Youssef Hussein; Juan Pedro Kusanovic; Yi Xu; Zhong Dong; Chong Jai Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2012-04-03

3.  Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member.

Authors:  Ian D Cooley; Vinita S Chauhan; Miguel A Donneyz; Ian Marriott
Journal:  Glia       Date:  2014-05       Impact factor: 7.452

4.  IL-19 is a component of the pathogenetic IL-23/IL-17 cascade in psoriasis.

Authors:  Ellen Witte; Georgios Kokolakis; Katrin Witte; Sandra Philipp; Wolf-Dietrich Doecke; Nina Babel; Bianca M Wittig; Katarzyna Warszawska; Agata Kurek; Magdalena Erdmann-Keding; Stefanie Kunz; Khusru Asadullah; Marshall E Kadin; Hans-Dieter Volk; Wolfram Sterry; Kerstin Wolk; Robert Sabat
Journal:  J Invest Dermatol       Date:  2014-07-21       Impact factor: 8.551

5.  Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly.

Authors:  Christian J Lechner; Karl Komander; Jana Hegewald; Xiangsheng Huang; Richard G Gantin; Peter T Soboslay; Abram Agossou; Meba Banla; Carsten Köhler
Journal:  Immun Ageing       Date:  2013-07-15       Impact factor: 6.400

6.  Anti-inflammatory effects of interleukin-19 in vascular disease.

Authors:  Ross N England; Michael V Autieri
Journal:  Int J Inflam       Date:  2012-07-15

7.  Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury.

Authors:  Yu-Hsiang Hsu; Hsing-Hui Li; Junne-Ming Sung; Wei-Ting Chen; Ya-Chin Hou; Ming-Shi Chang
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

Review 8.  Interleukin-19 in breast cancer.

Authors:  Ying-Yin Chen; Chien-Feng Li; Ching-Hua Yeh; Ming-Shi Chang; Chung-Hsi Hsing
Journal:  Clin Dev Immunol       Date:  2013-04-22

9.  Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progression.

Authors:  Chung-Hsi Hsing; Franky Antonius Kwok; Hung-Chi Cheng; Chien-Feng Li; Ming-Shi Chang
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

10.  The impact of breed and tissue compartment on the response of pig macrophages to lipopolysaccharide.

Authors:  Ronan Kapetanovic; Lynsey Fairbairn; Alison Downing; Dario Beraldi; David P Sester; Tom C Freeman; Christopher K Tuggle; Alan L Archibald; David A Hume
Journal:  BMC Genomics       Date:  2013-08-28       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.